Current Gene Therapy

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard
Nantes
France

Back

Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting open access plus

Volume:11   Issue:4
Pp: 241-258
Reeti Khare, Christopher Y. Chen, Eric A. Weaver and Michael A. Barry
DOI: 10.2174/156652311796150363

Order Reprints Order Eprints

Prospects and Limitations of T Cell Receptor Gene Therapy

Volume:11   Issue:4
Pp: 276-287
Annelies Jorritsma, Remko Schotte, Miriam Coccoris, Moniek A. de Witte and Ton N.M. Schumacher
DOI: 10.2174/156652311796150390

Order Reprints Order Eprints

Polycation-Based Gene Therapy: Current Knowledge and New Perspectives

Volume:11   Issue:4
Pp: 288-306
Marcio J. Tiera, Qin Shi, Francoise M. Winnik and Julio C. Fernandes
DOI: 10.2174/156652311796150408

Order Reprints Order Eprints

Adenoviral Vector Immunity: Its Implications and Circumvention Strategies

Volume:11   Issue:4
Pp: 307-320
Yadvinder S. Ahi, Dinesh S. Bangari and Suresh K. Mittal
DOI: 10.2174/156652311796150372

Order Reprints Order Eprints

Immune Responses to AAV in Clinical Trials open access plus

Volume:11   Issue:4
Pp: 321-330
Federico Mingozzi and Katherine A. High
DOI: 10.2174/156652311796150354

Order Reprints Order Eprints